Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Srpski Arhiv Za Celokupno Lekarstvo|May 1, 1994
[Carcinoembryonal antigen (CEA) in malignant lymphomas]V Kovcin, S Jelić, N Babović
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 1, 1994
A pilot study to assess the efficacy of salmon calcitonin in the relief of neuropathic pain caused by extraskeletal metastasesV Kovcin, S Jelić, N Babović, et al.
Srpski Arhiv Za Celokupno Lekarstvo|May 1, 1997
[Levels of immune complexes in fresh and frozen serum and plasma detected by precipitation with polyethylene glycol in patients with malignant diseases]V Kovcin, Z Juranić, N Babović, et al.
Tumori|March 18, 1999
Pilot study of daily ifosfamide 1 g/m2 until grade III granulocytopenia as second-line chemotherapy for anthracycline-pretreated advanced soft tissue sarcomaN Babović, S Jelić, N Milanović, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
EDTA clearance in monitoring cisplatin dose escalation in patients with bulky metastatic germ cell tumors of the testisS Jelić, V Kovcin, N Babović, et al.
Vojnosanitetski Pregled|March 1, 1995
[Anti-pain effect of salmon calcitonin in bone metastases of malignant tumors with the exception of breast and prostatic carcinoma]S Jelić, R Borkovacki, N Babović, et al.
Medical Oncology (Northwood, London, England)|March 29, 2002
Vinblastin-carboplatin for metastatic cutaneous melanoma as first-line chemotherapy and in dacarbazine failures: a single-center studyS Jelić, N Babović, L Stamatović, et al.
International Journal of Clinical Pharmacology Research|August 12, 2000
Epirubicin 150 mg/m2-cisplatin versus epirubicin 180 mg/m2-cisplatin for advanced soft tissue sarcomaS Jelić, N Babović, M Kreacić, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1997
Randomised study of high-dose epirubicin versus high-dose epirubicin-cisplatin chemotherapy for advanced soft tissue sarcomaS Jelić, V Kovcin, N Milanović, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2002
Use of high-dose cytarabine to enhance cisplatin cytotoxicity-effects on the response and overall survival rates of advanced head and neck cancer patientsS Jelić, Lj Stamatović, S Vucićević, et al.
Pageof 2